LINK FDA bans two monoclonal antibodies over omicron variant. Here's why.
The Food and Drug Administration pulled its authorization of two of the most used monoclonal antibodies to treat COVID-19 this week, leaving doctors with fewer options to help their patients avoid the hospital.
Why did the FDA shut them down?
Because the two, from drugmakers Regeneron and Eli Lilly, don't work against the omicron variant that now causes more than 99% of coronavirus infections in the United States
1
Enjoy being online again!
Welcome to the community of good people who base their values on evidence and appreciate civil discourse - the social network you will enjoy.Create your free account
Enjoy being online again!
Welcome to the community of good people who base their values on evidence and appreciate civil discourse - the social network you will enjoy.Create your free account
Share this post
Related Groups More
World Music
1329 members
Categories
Agnostic does not evaluate or guarantee the accuracy of any content. Read full disclaimer.